Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space
Ezhilarasan Devaraj, Elumalai Perumal, Raghunandhakumar Subramaniyan, Najimi Mustapha – 12 November 2021
The pathophysiology of Wilson’s disease visualized: A human 64Cu PET study
Thomas Damgaard Sandahl, Lars C. Gormsen, Kristoffer Kjærgaard, Mikkel Holm Vendelbo, Ditte Emilie Munk, Ole Lajord Munk, Dirk Bender, Susanne Keiding, Karina H. Vase, Kim Frisch, Hendrik Vilstrup, Peter Ott – 12 November 2021
Risk of HBV reactivation during therapies for HCC: A systematic review
Margarita Papatheodoridi, Maria Tampaki, Anna S. Lok, George V. Papatheodoridis – 12 November 2021
Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma
Lu Tian, Luqing Zhao, Karen Man‐Fong Sze, Charles Shing Kam, Vanessa Sheung‐In Ming, Xia Wang, Vanilla Xin Zhang, Daniel Wai‐Hung Ho, Tan‐To Cheung, Lo‐Kong Chan, Irene Oi‐Lin Ng – 11 November 2021
A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
Eun Ran Kim, Jeong Su Park, Jin Hee Kim, Ji Young Oh, In Jeong Oh, Da Hyun Choi, Yu seol Lee, I. Seul Park, SeungWon Kim, Da Hyun Lee, Jae Hee Cheon, Jin‐Woo Bae, Minyoung Lee, Jin Won Cho, In Bok An, Eun Joo Nam, Sang‐In Yang, Myung‐Shik Lee, Soo Han Bae, Yong‐ho Lee – 11 November 2021
Tripartite motif‐containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin‐proteasome–mediated degradation of pleckstrin homology domain leucine‐rich repeats protein phosphatase 1
Juan Yang, Jianming Ye, Tengfei Ma, Fangfang Tang, Li Huang, Zhen Liu, Song Tian, Xu Cheng, Li Zhang, Zhenli Guo, Fuping Tu, Miao He, Xueming Xu, Xiaojuan Lu, Yanyang Wu, Xiaoli Zeng, Jiahua Zou, Xiangcai Wang, Weijie Peng, Peng Zhang – 11 November 2021
Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients
Yana Davidov, Keren Tsaraf, Oranit Cohen‐Ezra, Mariya Likhter, Gil Ben Yakov, Itzchak Levy, Einav G. Levin, Yaniv Lustig, Orna Mor, Galia Rahav, Ziv Ben Ari – 11 November 2021 – The BNT162b2 messenger RNA (mRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been shown to be safe and effective in immunocompetent patients. The safety and efficacy of this vaccine in liver transplantation (LT) recipients is still under evaluation. The objective of this study was to assess the safety and efficacy of the BNT162b2 vaccine among transplant recipients.
Favorable impact in hepatitis C–related mortality following free access to direct‐acting antivirals in Spain
Julieta Politi, Juan‐Miguel Guerras, Marta Donat, María J. Belza, Elena Ronda, Gregorio Barrio, Enrique Regidor – 11 November 2021
LiverLearning®: 2021 Academic Debates
Explore timely topics in liver disease in a lively debate format as hepatology trainees and practicing hepatologists tackle important, often controversial issues. Debaters will gain skills in critical thinking, balanced argumentation and factual examination of each issues' pros and cons. Debaters, judges and audience members will grapple with opposing scientific, societal, individual and financial viewpoints on current clinical concerns.
LiverLearning®: 2021 Liver Transplantation and Surgery SIG: Evaluating Disparities in Access to and Outcomes of Liver Transplantation
Consider strategies to evaluate disparities in access to and outcomes of liver transplantation based on gender, patient age, race and ethnicity, and socioeconomic status at this stimulating seminar from the Liver Transplant and Surgery SIG. Learn how to evaluate the latest interventions to minimize care disparities and promote better long-term outcomes in transplant patients.